Stocks-OCUL-Ocular Therapeutix Inc

OCUL Ocular Therapeutix Inc

3.02 0.01 (0.33%)
Invest
Invest

Overview

Prev Close3.02
Day's Range 2.88 - 3.01
52 Week Range 2.77 - 7.36
Average Volume (3m)868.82K
1-Year Return-54.13%
Beta1.2896
Market Cap232.57M
P/E Ratio
Revenue49.73M
EPS-1.0098
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.715/06/202226/08/202207/11/20223.004.005.006.007.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Antony Mattessich
Employees 228

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Ocular Therapeutix Inc's revenues increased by 150.08% and amounted to 43.52M. Net income increased by 95.79% to -6.55M. Net assets increased by 15.64% to 88.00M and EPS increased from -2.56 to -0.98.
OCUL's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
90.68%
Net Profit Margin
-1,852.58%
Operating Margin
-155.53%
Return On Investment
-110.07%
12/21
03/22
06/22
09/22
Total Revenue
12.31M
13.19M
12.27M
11.97M
Gross Profit
11.2M
11.89M
11.11M
10.89M
Operating Income
-18.05M
-17.83M
-19.92M
-21.54M
Net Income
-3.85M
-12.54M
-18.77M
-24.19M